Epidemiological features and disease spectrum of hepatitis C in Qinghai Province, China: analysis of 110 cases

Huang YanWu; Han FengJuan

doi:10.3969/j.issn.1001-5256.2014.06.007

Issue 6

Jun. 2014

Turn off MathJax

Article Contents

Abstract

References

Article Navigation > Journal of Clinical Hepatology > 2014 > 30(6): 505-507

PDF( 1149 KB)

Epidemiological features and disease spectrum of hepatitis C in Qinghai Province, China: analysis of 110 cases

DOI: 10.3969/j.issn.1001-5256.2014.06.007

Department of Infectious Diseases, 536 Hospital of PLA

Received Date: 2013-07-05
Published Date: 2014-06-20

Abstract

Abstract

Objective To investigate the epidemiological features and disease spectrum of inpatients with hepatitis C in recent years and to provide reference for the control of hepatitis C. Methods A retrospective study of demography, epidemiology, and laboratory examination was performed in 110 hospitalized patients with hepatitis C. Results Of the 110 patients, 60 were male and 50 were female, with a male-to- female ratio of 1. 2: 1. The main transmission routes included blood product transfusion ( 33. 6%) , surgery ( 30. 0%) , intravenous drug use ( 14. 5%) , and sexual transmission ( 4. 5%) . The other 19 cases ( 17. 4%) were of unknown transmission route. The annual numbers of cases from 2008 to 2011 were 16, 18, 32, and 44, respectively. The genotype proportions in patients were as follows: 1b, 60. 7% ( 17 /28) ; 2a, 28. 6% ( 8 /28) ; 1b /2a mixed type, 7. 1% ( 2 /28) ; 3b, 3. 6% ( 1 /28) . Of all patients, 13. 6% ( 15 /110) were found with acute hepatitis C, 67. 3% ( 74 /110) with chronic hepatitis C, 19. 1% ( 21 /110) with liver cirrhosis, and 10. 9% ( 12 /110) with decompensated cirrhosis. Conclusion The incidence of HCV infection has been increasing year by year. The major HCV genotypes are 1b and2a. Hepatitis C is apt to develop into liver cirrhosis. It is necessary to reinforce monitoring and to carry out specific epidemiological study among the target population.
- hepatitis C,
- epidemiology,
- genotype

FullText(HTML)

References(11)

References

[1]LEMON SM, MCKEATING JA, PIETSCHMANN T, et al.Development of novel therapies for hepatitis C[J].Antiviral Res, 2010, 86 (1) :79-92.

[2]de BRUIJNE J, WEEGINK CJ, JANSEN PL, et al.New developments in the antiviral treatment of hepatitis C[J].Vox Sang, 2009, 97 (1) :1-12.

[3]Chinese Society of Hepatology and Chinese Society of Infectious Diseases and Parasitology, Chinese Medical Association.Guidelines for prevention and treatment of hepatitis C[J].J Clin Hepatol, 2004, 20 (4) :197-203. (in Chinese) 中华医学会肝病学分会、传染病与寄生虫病学分会.丙型肝炎防治指南[J].临床肝胆病杂志, 2004, 20 (4) :197-203.

[4]HAO XQ.Investigation of AIDS and hepatitis C in 277 patients receiving methadone replacement therapy[J].Qinghai Med J, 2009, 39 (6) :75-76. (in Chinese) 郝晓茜.277例美沙酮替代治疗者艾滋病、丙型肝炎感染的调查[J].青海医药杂志, 2009, 39 (6) :75-76.

[5]LI J, CHEN J, ZHUANG H, et al.Epidemiology of hepatitis C[J].J Clin Hepatol, 2012, 15 (5) :379-381. (in Chinese) 李杰, 陈杰, 庄辉, 等.丙型肝炎的流行病学[J].实用肝脏病杂志, 2012, 15 (5) :379-381.

[6]LIU N, SUN YJ, MAO Y, et al.The application of universalistic preventative measures in buccal clinic service[J/CD].Chin J Exp Clin Infect Dis:Electronic Edition, 2008, 2 (2) :72-79. (in Chinese) 刘楠, 孙玉娟, 毛羽, 等.普遍性预防措施在口腔门诊的应用[J/CD].中华实验和临床感染病杂志:电子版, 2008, 2 (2) :72-79.

[7] QIN QQ, GUO W, WANG LY, et al.Epidemiological characteristics of hepatitis C in China, 1997-2011[J].Chin J Epidemiol, 2013, 34 (6) :548-551. (in Chinese) 秦倩倩, 郭巍, 王丽艳, 等.1997-2011年中国丙型肝炎流行特征分析[J].中华流行病学杂志, 2013, 34 (6) :548-551.

[8]SU YY, LIU HX, WANG N, et al.Hepatitis C virus genotypes in China:a systematic review[J].Chin J Epidemiol, 2013, 34 (1) :80-84. (in Chinese) 苏迎盈, 刘慧鑫, 汪宁, 等.中国丙型肝炎病毒基因型分布[J].中华流行病学杂志, 2013, 34 (1) :80-84.

[9]WEI X, XIE YM, CHEN L, et al.Antiviral therapy with pegylated interferon alpha-2a plus ribavirin in patients with HCV related cirrhosis and to establish the grading for standard therapy[J].J Clin Hepatol, 2011, 27 (1) :89-92. (in Chinese) 魏欣, 谢玉梅, 陈琳, 等.丙型肝炎肝硬化的“分级”及聚乙二醇干扰素α-2a联合利巴韦林的抗病毒治疗[J].临床肝胆病杂志, 2011, 27 (1) :89-92.

[10]LAN HY, WANG AQ, YIN W.Advance in the research of experimental mouse model for hepatitis C virus[J].J Clin Hepatol, 2011, 27 (1) :36-39. (in Chinese) 兰海云, 汪爱勤, 尹文.丙型肝炎病毒小鼠实验模型的研究进展[J].临床肝胆病杂志, 2011, 27 (1) :36-39.

[11]European Association for the Study of the Liver.EASL clinical practice guidelines:management of hepatitis C virus infection[J].J Hepatol, 2011, 55 (2) :245-264.

Relative Articles

[1]	Yuanzhi HUANG, Fuchuan WANG, Yi DONG, Zhiqiang XU, Yinjie GAO, Jianguo YAN, Lili CAO, Danni FENG, Min ZHANG. Liver disease phenotypes and clinical features of patients with different genotypes of Wilson’s disease[J]. Journal of Clinical Hepatology, 2024, 40(8): 1627-1632. doi: 10.12449/JCH240819
[2]	Rui HAN, Liaoyun ZHANG. Clinical epidemiology and pathological features of cryptogenic cirrhosis[J]. Journal of Clinical Hepatology, 2022, 38(7): 1650-1653. doi: 10.3969/j.issn.1001-5256.2022.07.036
[3]	Jinni HUANG, Jianning JIANG, Dandan LIANG, Shiyu LONG, Guozhen DONG, Man SU, Jijiao LI, Chunling TENG, Ping ZHANG, Minghua SU. Epidemiological features and antiviral response of genotype 6 chronic hepatitis C[J]. Journal of Clinical Hepatology, 2022, 38(4): 793-797. doi: 10.3969/j.issn.1001-5256.2022.04.011
[4]	Chaomei QIN, Yongming LIU, Heling SU. Association of hepatitis B and hepatitis C with type 2 diabetes mellitus[J]. Journal of Clinical Hepatology, 2021, 37(4): 921-924. doi: 10.3969/j.issn.1001-5256.2021.04.042
[5]	Shan SHAN, Lianhui ZHAO, Hong MA, Xiaojuan OU, Hong YOU, Jidong JIA. Definition, etiology, and epidemiology of liver cirrhosis[J]. Journal of Clinical Hepatology, 2021, 37(1): 14-16. doi: 10.3969/j.issn.1001-5256.2021.01.003
[6]	Li Jing, Wang YuFang. Epidemiological features of inflammatory bowel disease with hepatobiliary and pancreatic diseases[J]. Journal of Clinical Hepatology, 2020, 36(7): 1461-1466. doi: 10.3969/j.issn.1001-5256.2020.07.005
[7]	Shu YunRan, Li JunQi, Liu Qiong. Epidemiology of nonalcoholic fatty liver disease and related risk factors[J]. Journal of Clinical Hepatology, 2019, 35(9): 2085-2090. doi: 10.3969/j.issn.1001-5256.2019.09.045
[8]	Hu JiangFeng, Lu LunGen. Research advances in the epidemiological features, pathogenesis, and diagnosis and treatment of alcoholic pancreatitis[J]. Journal of Clinical Hepatology, 2019, 35(2): 448-450. doi: 10.3969/j.issn.1001-5256.2019.02.047
[9]	Shen Tao, Huang Xin, Wang YuYa, Zhuang Hui. Current status of epidemiological studies on drug-induced liver injury in China[J]. Journal of Clinical Hepatology, 2018, 34(6): 1152-1155. doi: 10.3969/j.issn.1001-5256.2018.06.002
[10]	Li Jie. Epidemiology characteristics of nonalcoholic fatty liver disease in Asia[J]. Journal of Clinical Hepatology, 2018, 34(12): 2515-2519. doi: 10.3969/j.issn.1001-5256.2018.12.006
[11]	Ding YuPing, Li Hai, Zhang Wen, Xia ShiHai, Bi Xun. Epidemiological characteristics of nonalcoholic fatty liver disease with elevated alanine aminotransferase and related risk factors[J]. Journal of Clinical Hepatology, 2017, 33(12): 2355-2360. doi: 10.3969/j.issn.1001-5256.2017.12.020
[12]	Ding ShiMei, Qu Wei, Liang Xi, Jiao Yang, Zhang Jing, Jia XiaoLi, Wang WenJun, Dang ShuangSuo. Relationship between chronic hepatitis C virus genotype and thyroid function[J]. Journal of Clinical Hepatology, 2015, 31(8): 1271-1274. doi: 10.3969/j.issn.1001-5256.2015.08.021
[13]	Wang LiFeng, Li YuanYuan, Jin Lei, Wang FuSheng. Epidemiology and natural history of primary biliary cirrhosis[J]. Journal of Clinical Hepatology, 2015, 31(2): 165-170. doi: 10.3969/j.issn.1001-5256.2015.02.005
[14]	Zheng DongChun, Nie YuanXia, Liang HaiLin, Hu YueLin, Cheng Xiao, Feng XiaoXia, Chen YongPing. Epidemiological features and serological changes in sporadic acute hepatitis B among adults: an analysis of 202 cases[J]. Journal of Clinical Hepatology, 2014, 30(1): 30-33. doi: 10.3969/j.issn.1001-5256.2014.01.009
[15]	Jiang ShuiQing, Wang Jian, Hu XiaoBin, Li YuZhi, Lu YouJie, Tong Rui, Tong Min. Epidemiology and treatment strategies for hepatitis C in the northern region of Anhui province[J]. Journal of Clinical Hepatology, 2012, 28(12): 937-940.
[16]	Cheng Ling, Hong GuoHu, Guo Yan, Mao Qing. Prediction of HLA-DRB1*0311/0401 in recognizing epitopes of HCV Core protein of different genotypes[J]. Journal of Clinical Hepatology, 2011, 27(1): 61-64.
[17]	Zhang WenJie, Liu LiJun, Du ShaoCai, Li ChaoXia, Lu QingYun, Yang ShaoHua. The prevalence of hepatitis C virus genotype in Lanzhou area[J]. Journal of Clinical Hepatology, 2010, 26(3): 290-291+294.
[19]	Chen Yan, Tian DeYing, Xia NingShao. Epidemiology and the genotypes of HEV isolated from patients with hepatitis E in Wuhan[J]. Journal of Clinical Hepatology, 2006, 22(1): 36-38.
[20]	Li TingMing, Zhu YouFu, He HaiTang, Mao QianGuo, Wu AiHua, Liang YuFang, Luo KangXian. The relation between chinese hepatitis B virus genotype B C and efficacy of interferon-α.[J]. Journal of Clinical Hepatology, 2005, 21(1): 16-18.

Supplements(0)

Cited By

Proportional views

Proportional views

通讯作者: 陈斌, bchen63@163.com

1.
沈阳化工大学材料科学与工程学院沈阳 110142

Get Citation

PDF

XML

Article Metrics

Article views (2996) PDF downloads(604)

Epidemiological features and disease spectrum of hepatitis C in Qinghai Province, China: analysis of 110 cases

DOI: 10.3969/j.issn.1001-5256.2014.06.007

Abstract

References

Relative Articles

Proportional views

Catalog

通讯作者: 陈斌, bchen63@163.com

Article Metrics

Proportional views

Related

Epidemiological features and disease spectrum of hepatitis C in Qinghai Province, China: analysis of 110 cases

DOI: 10.3969/j.issn.1001-5256.2014.06.007

Abstract

References

Relative Articles

Proportional views

Catalog

通讯作者: 陈斌, bchen63@163.com

Article Metrics

Proportional views

Related

About Journal

Submission Guideline

Journal Online

Hepatobiliary College

Guidelines

Export File

Citation

Format

Content